Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

Université de Montréal

$110,000.00

Long-term use of proton pump inhibitors: an overlooked risk factor of vitamin B12 deficiency?

FY 2012-13

Summary
Vitamin B12 deficiency is common in Canada. It causes anemia and neurological symptoms (ex. foot numbness). Undiagnosed vitamin B12 deficiency can lead to severe and irreversible damage to the nervous system. It is thus important to know who is at risk of vitamin B12 deficiency in order to periodically evaluate their status and ensure early treatment. Vitamin B12 deficiency is primarily caused by the malabsorption of vitamin B12. Most often, it is the lack of gastric acid that alters absorption. Given that, gastric acid-lowering drugs (ex: Nexium®, Pantoloc®) are increasingly thought to be a risk factor of vitamin B12 deficiency, especially in older adults to whom these drugs are the most frequently prescribed. To date, seven studies have been published on this topic. However, their results are equivocal because of important biases in their methods. A major concern is that none of them took into consideration vitamin B12 intake, either from food (ex. meat, dairy products) or supplements (ex. multivitamins). Because it is not yet a well-established risk factor, physicians do not routinely screen their patients treated with gastric acid-lowering agents for vitamin B12 deficiency. Accordingly, our main objective is to unequivocally determine whether users of gastric acid-lowering agents are more at risk of vitamin B12 deficiency over time while taking into account the amount of vitamin B12 they consumed through foods or supplements. In the present application, we propose to conduct a study based on a sample of >1000 older adults whose were followed during four years. More than 18% are taking gastric acid-lowering drugs. The results will allow determining whether patients treated with gastric acid-lowering drugs should be periodically screened for vitamin B12 deficiency. A better understanding of this potential risk factor will help preventing serious and costly conditions such as anemia and irreversible neurological damages.
Program
CIHR Fellowship
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
281955
Name
Presse Nancy
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Clinical
Prcname2
Allied Health Professionals - Fellowships
Projecttitle
Long-term use of proton pump inhibitors: an overlooked risk factor of vitamin B12 deficiency?
Programtype2
Fellowship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$110,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Gastric Acid-Lowering Agents; Nutritional Deficiency; Proton Pump Inhibitors; Vitamin B12
Abstract
Vitamin B12 deficiency is common in Canada. It causes anemia and neurological symptoms (ex. foot numbness). Undiagnosed vitamin B12 deficiency can lead to severe and irreversible damage to the nervous system. It is thus important to know who is at risk of vitamin B12 deficiency in order to periodically evaluate their status and ensure early treatment. Vitamin B12 deficiency is primarily caused by the malabsorption of vitamin B12. Most often, it is the lack of gastric acid that alters absorption. Given that, gastric acid-lowering drugs (ex: Nexium®, Pantoloc®) are increasingly thought to be a risk factor of vitamin B12 deficiency, especially in older adults to whom these drugs are the most frequently prescribed. To date, seven studies have been published on this topic. However, their results are equivocal because of important biases in their methods. A major concern is that none of them took into consideration vitamin B12 intake, either from food (ex. meat, dairy products) or supplements (ex. multivitamins). Because it is not yet a well-established risk factor, physicians do not routinely screen their patients treated with gastric acid-lowering agents for vitamin B12 deficiency. Accordingly, our main objective is to unequivocally determine whether users of gastric acid-lowering agents are more at risk of vitamin B12 deficiency over time while taking into account the amount of vitamin B12 they consumed through foods or supplements. In the present application, we propose to conduct a study based on a sample of >1000 older adults whose were followed during four years. More than 18% are taking gastric acid-lowering drugs. The results will allow determining whether patients treated with gastric acid-lowering drugs should be periodically screened for vitamin B12 deficiency. A better understanding of this potential risk factor will help preventing serious and costly conditions such as anemia and irreversible neurological damages.
Competitiondate
201302
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Presse, Nancy
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $110,000~ $0~